Concepedia

Huifeng Niu

HN

14

Publications

1.5K

Citations

14

H-Index

1995

Active since

Affiliations

Takeda (United States)(Current)

Millennium Engineering and Integration (United States)

La Roche College

University of Parma

Columbia University

Huifeng Niu is an author at Takeda (United States) specializing in immunology, medicine, and tumor biology.

ORCID

Top concepts

Publications per year

1995–2023

14

Publications

14

Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial

D. Ross Camidge, Hye Ryun Kim, Myung‐Ju Ahn et al. · Journal of Thoracic Oncology · 2021 · 350 citations · Full text

Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.

B. H. Ye, Subba Rao Chaganti, Chia‐Che Chang et al. · The EMBO Journal · 1995 · 281 citations · Full text

, , +9

Tracking CD40 signaling during germinal center development

Katia Basso, Ulf Klein, Huifeng Niu et al. · Blood · 2004 · 176 citations · Full text

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

Taofeek K. Owonikoko, Huifeng Niu, Kristiaan Nackaerts et al. · Journal of Thoracic Oncology · 2019 · 141 citations · Full text

BCL6 Controls the Expression of the B7-1/CD80 Costimulatory Receptor in Germinal Center B Cells

Huifeng Niu, Giorgio Cattoretti, Riccardo Dalla‐Favera · The Journal of Experimental Medicine · 2003 · 98 citations · Full text

Rows per page

1–5 of 14